Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fixed vs Free Perindopril/Indapamide/Amlodipine in Hypertension
NCT05820880Phase 3Completed
- Sponsor
- Servier
- Start
- May 2019
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of perindopril, indapamide, amlodipine in essential hypertension, sponsored by Servier. Started May 2019; status: completed.
02
Drugs
perindoprilindapamideamlodipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT05820880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05820880.